Financial News
Latest News about IDYA
Recent news which mentions IDYA
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Experts
February 21, 2024
Tickers
IDYA
From Benzinga
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts
January 26, 2024
Tickers
IDYA
From Benzinga
Goldman Sachs Maintains Buy Rating for IDEAYA Biosciences: Here's What You Need To Know
January 25, 2024
Tickers
IDYA
From Benzinga
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
From Benzinga
Why IDEAYA Biosciences Stock Is Falling During Wednesday's Session
October 25, 2023
Tickers
IDYA
From Benzinga
Alphabet, Texas Instruments, CoStar Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
October 25, 2023
From Benzinga
Adobe To Rally Over 14%? Here Are 10 Other Analyst Forecasts For Tuesday
September 12, 2023
From Benzinga
Top 5 Health Care Stocks That May Fall Off A Cliff
September 06, 2023
From Benzinga
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
August 09, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
From Benzinga
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 24, 2023
From Benzinga
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 24, 2023
From Benzinga
From Benzinga
IDEAYA Biosciences Touts Encouraging Data From Combo Therapy For Rare Eye Cancer Impacting Around 14,000 In US and Europe
April 24, 2023
Tickers
IDYA
From Benzinga
US Stocks Edge Higher; Coca-Cola Posts Upbeat Results
April 24, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.